» Articles » PMID: 38797825

The Burdens Attributable to Primary Headache Disorders in Children and Adolescents in Iran: Estimates from a Schools-based Study

Overview
Journal J Headache Pain
Publisher Biomed Central
Date 2024 May 26
PMID 38797825
Authors
Affiliations
Soon will be listed here.
Abstract

Background: We recently found headache disorders to be highly prevalent among children (aged 6-11 years) and adolescents (aged 12-17) in Iran (gender- and age-adjusted 1-year prevalences: migraine 25.2%, tension-type headache 12.7%, undifferentiated headache [UdH] 22.1%, probable medication-overuse headache [pMOH] 1.1%, other headache on ≥ 15 days/month [H15+] 3.0%). Here we report on the headache-attributed burden, taking evidence from the same study.

Methods: In a cross-sectional survey, following the generic protocol for the global schools-based study led by the Global Campaign against Headache, we administered the child and adolescent versions of the Headache-Attributed Restriction, Disability, Social Handicap and Impaired Participation (HARDSHIP) structured questionnaire in 121 schools, purposively selected to reflect the country's diversities. Pupils self-completed these in class, under supervision. Headache diagnostic questions were based on ICHD-3 criteria but for the inclusion of UdH (defined as mild headache with usual duration < 1 h). Burden enquiry was across multiple domains.

Results: The analysed sample (N = 3,244) included 1,308 (40.3%) children and 1,936 (59.7%) adolescents (1,531 [47.2%] male, 1,713 [52.8%] female). The non-participating proportion was 3.4%. Mean headache frequency was 3.9 days/4 weeks, and mean duration 1.8 h. Estimated mean proportion of time in ictal state was 1.1% (1.4% for migraine, 16.5% for pMOH). Symptomatic medication was consumed on a mean of 1.6 days/4 weeks. Lost school time averaged 0.4 days/4 weeks overall (2%, assuming a 5-day week), but was eleven-fold higher (4.3 days; 22%) for pMOH. For most headache types, days of reported limited activity were several-fold more than days lost from school (45% for pMOH, 25% for other H15+). Almost one in 12 parents (7.9%) missed work at least once in 4 weeks because of their son's or daughter's headache. Emotional impact and quality-of-life scores reflected these measures of burden.

Conclusions: Headache, common in children and adolescents in Iran, is associated with symptom burdens that may be onerous for some but not for most. However, there are substantial consequential burdens, particularly for the 1.1% with pMOH and the 3.0% with other H15+, who suffer educational disturbances and potentially major life impairments. These findings are of importance to educational and health policies in Iran.

Citing Articles

Calcitonin-Gene-Related Peptide in Migraine and Tension-Type Headache in Children During Interictal Period.

Sekelj Fures J, Duranovic V, Lenicek Krleza J, Bojanac A, Loncar L, Dakovic I Diagnostics (Basel). 2024; 14(23).

PMID: 39682553 PMC: 11640429. DOI: 10.3390/diagnostics14232645.

References
1.
. Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition. Cephalalgia. 2018; 38(1):1-211. DOI: 10.1177/0333102417738202. View

2.
. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015; 386(9995):743-800. PMC: 4561509. DOI: 10.1016/S0140-6736(15)60692-4. View

3.
Luvsannorov O, Tsenddorj B, Baldorj D, Enkhtuya S, Purev D, Thomas H . Primary headache disorders among the adult population of Mongolia: prevalences and associations from a population-based survey. J Headache Pain. 2019; 20(1):114. PMC: 6916065. DOI: 10.1186/s10194-019-1061-5. View

4.
Genc D, Vaiciene-Magistris N, Zaborskis A, Sasmaz T, Yeniocak Tunc A, Uluduz D . The prevalence of headache disorders in children and adolescents in Lithuania: a schools-based study. J Headache Pain. 2020; 21(1):73. PMC: 7288438. DOI: 10.1186/s10194-020-01146-x. View

5.
Togha M, Nadjafi-Semnani F, Martami F, Mohammadshirazi Z, Vahidpour N, Akbari-Sari A . Economic burden of medication-overuse headache in Iran: direct and indirect costs. Neurol Sci. 2020; 42(5):1869-1877. DOI: 10.1007/s10072-020-04716-8. View